RODERIC SMITH
Medical Practice at 42 Ave, Anchorage, AK

License number
Alaska MEDS4904
Issued Date
Aug 5, 2002
Expiration Date
Dec 31, 2016
Category
Medical
Address
Address
2401 E 42Nd Ave STE 306, Anchorage, AK 99508

Organization information

See more information about RODERIC SMITH at bizstanding.com

Pediatric Neurology Clinic

2401 E 42 Ave, Anchorage, AK 99508

Industry:
Offices of Physicians (except Mental Health Specialists)
Doing business as:
Pediatric Neurology Clinic - Roderic Smith MD
Registration:
Dec 3, 2006
Phone:
(907) 562-6300 (Phone), (907) 562-6305 (Fax)
Description:
Offices and Clinics of Medical Doctors
SIC:
8011 - Offices and Clinics of Doctors of Medicine
Categories:
Physicians & Surgeons - Medical-M.D., Clinics & Medical Centers, Medical Diagnostic Clinics
Specialties:
Neurology
In practice since:
2002
Products:
Neonatal & Newborn Care
Company size:
19

Professional information

Roderic L Smith Photo 1

Dr. Roderic L Smith, Anchorage AK - MD (Doctor of Medicine)

Specialties:
Pediatric Neurology
Address:
Pediatric Neurology Clinic
2401 E 42Nd Ave STE 306, Anchorage 99508
(907) 562-6300 (Phone), (907) 562-6305 (Fax)
Certifications:
Neurology with Special Qualification in Child Neurology, 1993
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Washington Center / School of Medicine
Graduated: 1987
Uchsc


Roderic Smith Photo 2

Roderic Smith, Anchorage AK

Work:
%Pediatric Neurology Clinic
2401 E 42Nd Ave, Anchorage, AK 99508


Roderic Smith Photo 3

Chlorine Ion Uptake Modulators And Uses Thereof

US Patent:
2007004, Feb 22, 2007
Filed:
Aug 16, 2006
Appl. No.:
11/464977
Inventors:
Kevin Staley - Denver CO, US
Volodya Dzhala - Denver CO, US
Frances Jensen - Chestnut Hill MA, US
Roderic Smith - Anchorage AK, US
International Classification:
A61K 31/5513, A61K 31/549, A61K 31/515, A61K 31/195
US Classification:
514221000, 514223200, 514471000, 514563000, 514562000, 514270000
Abstract:
The present invention provides methods for using chloride ion uptake modulators to treat disorders that are mediated by a sodium/potassium/chloride cotransporter.